Immunic Inc.

NASDAQ: IMUX · Real-Time Price · USD
0.98
0.08 (8.72%)
At close: Aug 18, 2025, 2:56 PM

Immunic Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-100.51M -93.61M -120.41M -92.94M
Depreciation & Amortization
134K 111K 77K 85K
Stock-Based Compensation
8.53M 7.1M 7.93M 5.95M
Other Working Capital
-2.58M 14.23M 8.73M -9.46M
Other Non-Cash Items
6.52M 523K 37.73M 8.63M
Deferred Income Tax
n/a n/a n/a 4.33M
Change in Working Capital
564K 15.05M 9.53M -9.28M
Operating Cash Flow
-84.77M -70.83M -65.14M -83.23M
Capital Expenditures
-264K -334K -112K -67K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a -9.63M n/a
Sales Maturities Of Investments
n/a 9.8M n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-264K 9.46M -9.74M -67K
Debt Repayment
74.27M n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
77K 180K 187K 92K
Financial Cash Flow
74.54M 1.03M 95.76M 42.84M
Net Cash Flow
-11.01M -60.07M 19.88M -40.59M
Free Cash Flow
-85.03M -71.16M -65.26M -83.3M